| RS8192605 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to pro-opiomelanocortin deficiency, Obesity |
| RS8192606 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to pro-opiomelanocortin deficiency, Obesity |
| RS8192683 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, autosomal recessive |
| RS8192690 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS8192833 |
TBXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS8193031 |
TGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 1, TGM1-related disorder |
| RS832032 |
GABRR3
|
Health Risk |
Likely risk allele |
Restless legs, Restless legs |
| RS863223276 |
IYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosine deiodination defect, IYD-related disorder |
| RS863223277 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS863223279 |
SMC3
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 3, Cornelia de Lange syndrome 3 |
| RS863223280 |
CFC1
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS863223281 |
TRIP11
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IA |
| RS863223282 |
GPC6
|
Health Risk |
Pathogenic |
Autosomal recessive omodysplasia, Autosomal recessive omodysplasia |
| RS863223283 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS863223284 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS863223285 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS863223286 |
CCN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive pseudorheumatoid dysplasia, CCN6-related disorder |
| RS863223287 |
BMPR1B
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 3, Acromesomelic dysplasia 3 |
| RS863223288 |
TNFSF11
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 2, Autosomal recessive osteopetrosis 2 |
| RS863223289 |
ROR2
|
Health Risk |
Pathogenic |
Brachydactyly type B1, Brachydactyly type B1 |
| RS863223290 |
ROR2
|
Health Risk |
Pathogenic |
Brachydactyly type B1, Robinow syndrome |
| RS863223291 |
ROR2
|
Health Risk |
Pathogenic |
Autosomal recessive Robinow syndrome, Autosomal recessive Robinow syndrome |
| RS863223292 |
ROR2
|
Health Risk |
Pathogenic |
Brachydactyly type B1, Brachydactyly type B1 |
| RS863223293 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency 1 |
| RS863223294 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS863223295 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS863223296 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS863223297 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS863223298 |
FLNA
|
Health Risk |
Pathogenic |
Otopalatodigital syndrome spectrum disorder, Otopalatodigital syndrome spectrum disorder |
| RS863223299 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS863223301 |
TP53
|
Health Risk |
Pathogenic |
Choroid plexus papilloma, Bone osteosarcoma |
| RS863223302 |
SPTB
|
Health Risk |
Pathogenic |
Elliptocytosis 3, Elliptocytosis 3 |
| RS863223303 |
SPTB
|
Health Risk |
Pathogenic |
Elliptocytosis 3, Elliptocytosis 3 |
| RS863223304 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS863223305 |
SPTA1
|
Health Risk |
Pathogenic |
Elliptocytosis 2, Elliptocytosis 2 |
| RS863223306 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Autosomal dominant isolated somatotropin deficiency |
| RS863223307 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Idiopathic growth hormone deficiency |
| RS863223308 |
GH1
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency type IB, Isolated growth hormone deficiency type IB |
| RS863223309 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Autosomal dominant isolated somatotropin deficiency |
| RS863223310 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Autosomal dominant isolated somatotropin deficiency |
| RS863223311 |
MEN1
|
Health Risk |
Pathogenic |
Hyperparathyroidism 1, Hereditary cancer-predisposing syndrome |
| RS863223312 |
MLH1
|
Health Risk |
Pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS863223314 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS863223315 |
ALDH18A1
|
Health Risk |
Pathogenic |
ALDH18A1-related de Barsy syndrome, ALDH18A1-related de Barsy syndrome |
| RS863223316 |
SLC33A1
|
Health Risk |
Pathogenic |
Huppke-Brendel syndrome, Huppke-Brendel syndrome |
| RS863223317 |
SMOC1
|
Health Risk |
Pathogenic |
Microphthalmia with limb anomalies, Microphthalmia with limb anomalies |
| RS863223318 |
ANKRD26
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocytopenia 2, Thrombocytopenia |
| RS863223319 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS863223320 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS863223321 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS863223322 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS863223324 |
TINF2
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 3 |
| RS863223325 |
DRC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 27, Primary ciliary dyskinesia |
| RS863223326 |
LBR
|
Health Risk |
Pathogenic |
Pelger-Huët anomaly, Greenberg dysplasia |
| RS863223330 |
SIX1
|
Health Risk |
Likely pathogenic |
Branchiootic syndrome 3, Branchiootic syndrome 3 |
| RS863223331 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS863223335 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Fetal akinesia deformation sequence 1 |
| RS863223336 |
RTEL1
|
Health Risk |
Pathogenic/Likely risk allele |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS863223338 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS863223339 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS863223340 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS863223341 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 8 |
| RS863223342 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS863223343 |
PANK2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS863223344 |
PCARE
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS863223345 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS863223346 |
FREM2
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223347 |
SEZ6
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223348 |
GALNT4;POC1B;POC1B-DUSP6;POC1B-GALNT4
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223349 |
ITGA6
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223350 |
GTF2IRD1
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223351 |
STAC2
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223352 |
ARL16
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223353 |
MEST
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223354 |
RYR2
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223355 |
RYR2
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223356 |
RELA
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS863223361 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Abnormality of neuronal migration, Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures |
| RS863223377 |
WDR62
|
Health Risk |
Pathogenic |
Abnormality of neuronal migration, Abnormality of neuronal migration |
| RS863223396 |
WDR73
|
Health Risk |
Likely pathogenic |
Galloway-Mowat syndrome 1, Galloway-Mowat syndrome 1 |
| RS863223398 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS863223401 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 6, Progressive myoclonic epilepsy type 6 |
| RS863223402 |
HNRNPK
|
Health Risk |
Pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS863223403 |
HNRNPK
|
Health Risk |
Pathogenic/Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS863223404 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS863223405 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Ichthyosis |
| RS863223406 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223408 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension, Epistaxis |
| RS863223409 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223410 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS863223411 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS863223412 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223413 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223414 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223415 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223416 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS863223417 |
ACVRL1
|
Health Risk |
Pathogenic |
— |
| RS863223418 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS863223419 |
BMPR2
|
Health Risk |
Pathogenic |
Idiopathic and/or familial pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS863223420 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |